Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¹é¼­ÀÇ ½ÇÇèÀû °£ ¼¶À¯Áõ½Ä¿¡¼­ ¸é¿ª¾ïÁ¦ ¹× Áõ°­Á¦¿¡ ÀÇÇÑ ºñÀå¼¼Æ÷ Subset º¯È­¿¡ °üÇÑ ¿¬±¸ The Effects of Immunosuppressant and Immunostimulant on the Splenic Cell Subset of Rats Having Undergone Experimentally Induced Septal Fibrosis of Liver

´ëÇѺ´¸®ÇÐȸÁö 1995³â 29±Ç 5È£ p.572 ~ 583
¼³¹Ì¿µ, ±èÁØ¿¬, Á¤±Ô¼·,
¼Ò¼Ó »ó¼¼Á¤º¸
¼³¹Ì¿µ (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

±èÁØ¿¬ (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¤±Ô¼· (  ) 
ºÎ»ê´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract

¿ä ¾à
°£ ¼¶À¯È­ÀÇ ¹ß»ý¿¡ ºñÀåÀÇ ¿ªÇÒÀÌ Áß¿äÇÏ´Ù´Â º¸°íµéÀÌ ÀÖ´Ù. ±×·¯³ª ±× ±âÀü¿¡ °üÇÏ¿©´Â
¾ÆÁ÷ ºÒ¸íÇÑ Á¡ÀÌ ¸¹´Ù. ÀúÀÚ´Â ºñÀåÀÌ °£ ¼¶À¯È­¿¡ °ü¿©ÇÏ´Â ±âÀüÀÇ ÀÏ´ÜÀ» ±¸¸íÇÒ ¸ñÀûÀ¸
·Î ÀÌ ¿¬±¸¸¦ ½ÃµµÇÏ¿´´Ù.
Á¤»ó ÈòÁã¿¡ µÅÁöÇ÷ûÀ» º¹°­³»¿¡ ÁÖ»çÇÏ¿© °£ ¼¶À¯È­À» ÀÏÀ¸Å°´Â ½ÇÇè¿¡ À־ µÅÁöÇ÷û
´Üµ¶, ÀÌ°Í°ú Freund's adjuvant, ¶Ç´Â cyclosporin A¸¦ ÇÔ²² Åõ¿©ÇÏ¿© °£ ¼¶À¯È­ÀÇ Á¤µµ ¹×
ºñÀå¼¼Æ÷ subsetÀÇ ºñÀ²º¯µ¿À» ºñ±³ °ËÅäÇÏ¿´´Ù. ÀÌ·¸°Ô ÇÏ¿© ¾òÀº ¼ºÀûÀ» ¿ä¾àÇÏ¸é ´ÙÀ½°ú
°°´Ù.
1) °£ ¼¶À¯È­´Â µÅÁöÇ÷û ´Üµ¶ Åõ¿©¿¡ À־ ÁÖÀÔ½ÃÀÛ ÈÄ 6ÁÖ°¿Í 8ÁÖ°¿¡ °¢°¢ 5¸¶¸® Áß
3¸¶¸®¿¡¼­, 10ÁÖ°¿¡ 5¸¶¸® Áß 4¸¶¸®¿¡¼­, ±×¸®°í 12ÁÖ°¿¡ 5¸¶¸® ÀüºÎ¿¡¼­ °æÇÏ°Ô ¶Ç´Â Çö
ÀúÇÏ°Ô ³ªÅ¸³µ°í, µÅÁöÇ÷û°ú adjuvant Åõ¿©±º¿¡ À־ 4ÁÖ°¿¡ 5¸¶¸® Áß 1¸¶¸®¿¡¼­ ±×¸®
°í 6ÁÖ°¿¡¼­ 12ÁÖ°±îÁö¿¡ 5¸¶¸® ÀüºÎ¿¡¼­ °æÇÏ°Ô ¶Ç´Â ÇöÀúÇÏ°Ô ³ªÅ¸³µÀ¸¸ç, µÅÁöÇ÷û°ú
cyclosporine Åõ¿©±º¿¡ À־ 8ÁÖ°¿¡ 5¸¶¸® Áß 2¸¶¸®¿¡¼­ °í¸®°í 10ÁÖ°¿Í 12ÁÖ°¿¡ 5¸¶
¸® Áß 1¸¶¸®¿¡¼­ °æÇÏ°Ô ³ªÅ¸³µ´Ù.
2) ºñÀåÀÇ Á¶Á÷ÇÐÀû ¼Ò°ß¿¡ À־ µÅÁöÇ÷û ´Üµ¶Åõ¿©±º¿¡¼­´Â ÁÖÀÔ½ÃÀÛ ÈÄ 6ÁÖ°¿¡ Áß½É
µ¿¸Æ ÁÖÀ§¹é¼ö°¡ È®´ëµÇ¾ú°í ¹èÁß½ÉÀÌ ÃâÇöÇÏ¿© 8Ãß ÀÌÈÄ¿¡´Â Á¡Â÷ Á¶±Ý¾¿ ½ÉÇÏ¿©Á³°í, µÅ
ÁöÇ÷û°ú adjuvant Åõ¿© ±º¿¡¼­´Â 4ÁÖ°ºÎÅÍ ºñ½ÁÇÑ ¼Ò°ßÀÌ ³ªÅ¸³ª Á¡Â÷ ½ÉÇÏ¿©Á³À¸¸ç, µÅ
ÁöÇ÷û°ú cyclosporine Åõ¿©±º¿¡¼­´Â º° º¯µ¿ÀÌ ÀÎÁ¤µÇÁö ¾Æ´ÏÇÏ¿´´Ù.
3) ºñÀå¼¼Æ÷ subset ºñÀ²ÀÇ º¯µ¿¿¡ À־ B-¼¼Æ÷ ºñÀ²Àº µÅÁöÇ÷û ´Üµ¶ Åõ¿©±º¿¡¼­´Â ÁÖ
ÀÔ½ÃÀÛ ÈÄ 8 ÁÖ°ºÎÅÍ °¨¼ÒÇÏ¿´°í, µÅÁöÇ÷û°ú adjuvant Åõ¿©±º¿¡¼­´Â º° º¯µ¿ÀÌ ¾ø¾úÀ¸¸ç,
µÅÁöÇ÷û°ú cyclosporine Åõ¿©±º¿¡¼­´Â 4ÁÖ°ºÎÅÍ ÇöÀúÇÏ°Ô °¨¼ÒÇÏ¿´´Ù.
CD4+ ¼¼Æ÷ ºñÀ²Àº µÅÁöÇ÷û ´Üµ¶ Åõ¿©±º°ú µÅÁöÇ÷û°ú cyclosporine Åõ¿©±º¿¡¼­´Â ÁÖÀÔÈÄ
4ÁÖ°¿Í 6ÁÖ°¿¡ °¨¼ÒÇÏ¿´À¸³ª, µÅÁöÇ÷û°ú adjuvant Åõ¿©±º¿¡¼­´Â º° º¯µ¿ÀÌ ¾ø¾ú´Ù. CD8+
¼¼Æ÷ ºñÀ²Àº µÅÁöÇ÷û ´Üµ¶ Åõ¿©±º°ú µÅÁöÇ÷û°ú cyclosporine Åõ¿©±º¿¡¼­´Â 8ÁÖ ÀÌÈĺÎÅÍ
Áõ°¡ÇÏ¿´À¸³ª, µÅÁöÇ÷û°ú adjuvant Åõ¿©±º¿¡¼­´Â º° º¯µ¿ÀÌ ¾ø¾ú´Ù. ºñÀå ´ë½Ä¼¼Æ÷ ºñÀ²Àº
µÅÁöÇ÷û ´Üµ¶ Åõ¿©±º°ú µÅÁöÇ÷û°ú cyclosporine Åõ¿©±º¿¡¼­´Â º° º¯µ¿ÀÌ ¾ø¾úÀ¸³ª, µÅÁöÇ÷
û°ú adjuvant Åõ¿©±º¿¡¼­´Â ÁÖÀÔ½ÃÀÛ ÈÄ Ãʱâ(4ÁÖ°¿Í 6ÁÖ°)¿¡ ½ÉÇÏ°Ô °¨¼ÒÇÏ¿´´Ù.
ÀÌ»óÀÇ ¼ºÀû¿¡ ÀÇ°ÅÇÏ¸é µÅÁöÇ÷û¿¡ ÀÇÇÑ °£ ¼¶À¯È­´Â adjuvant¿¡ ÀÇÇÏ¿© ÃËÁøµÇ°í
cyclosporine¿¡ ÀÇÇÏ¿© ¾ïÁ¦µÇ¸ç, µÅÁöÇ÷û¿¡ ÀÇÇÑ ºñÀå¼¼Æ÷ subset ºñÀ²ÀÇ º¯µ¿¿¡ À־
B-¼¼Æ÷¿Í CD4+ ¼¼Æ÷ ºñÀ²Àº °¨¼ÒÇÏ°í CD8+ ¼¼Æ÷ ºñÀ²Àº Áõ°¡Çϴµ¥ ÀÌ·± º¯µ¿Àº adjuvan
¶¼ ÀÇÇÏ¿© ÃËÁøµÇ°í cyclosporine¿¡ ÀÇÇÏ¿© ¾ïÁ¦µÇ¸ç, ´ë½Ä¼¼Æ÷ ºñÀ²Àº À¯ÀÇÀû º¯µ¿ÀÌ »ý±â
Áö ¾Æ´ÏÇϳª adjuvant¿¡ ÀÇÇÏ¿© ÇöÀúÇÏ°Ô °¨¼ÒÇÑ´Ù°í »ý°¢µÇ¾ú´Ù.
#ÃÊ·Ï#
Although there have been many reports about the importance of the spleen's role in
hepatic fibrogenesis, the exact mechanism is still uncertain. The author designed this
study to evaluate splenic function on hepatic fibrogenesis.
The degree of hepatic fibrosis and the population of splenocyte subsets were studied in
the experimental animal model with fibrosis produced by injecting normal swine serum
intraperitoneally into Sprague-Dawley rats. The animals were divided into three groups;
group A was subjected to injection of swine serum only, group B swine serum and
complete Freund's adjuvant, and group C swine serum and cyclosporin A. The
experimental hepatic fibrogenesis by swine serum was augumented by coinjection with
the adjuvant and inhibited by cyclosporin A.
The study of the splenocyte subset revealed increased percentages of splenic B cell and
CD4+ cell and a decreased percentage of CD8+ cell, and these changes of splenocyte
subset were also augumented by the adjuvant and inhibited by cyclosporin A. The
percent of monocytes was not significantly altered, although a tendancy of early
decrease by the adjuvant was noted.

Å°¿öµå

Hepatic fibrosis; Splenocyte svbsets; Freund's adjuvant; Cyclosporin A;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS